2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol

98%

Reagent Code: #232191
fingerprint
CAS Number 1863036-49-0

science Other reagents with same CAS 1863036-49-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 578.63 g/mol
Formula C₂₆H₃₂F₂N₆O₅S
inventory_2 Storage & Handling
Storage Room temperature

description Product Description

Used in the treatment of hepatitis C virus (HCV) infection. It acts as a nucleotide analog inhibitor of the NS5B RNA-dependent RNA polymerase, an enzyme essential for viral replication. By incorporating into the growing RNA chain, it causes premature termination of viral RNA synthesis, effectively suppressing the virus. This compound is part of combination antiviral therapies designed to achieve high cure rates with shorter treatment durations and minimal side effects. Its high barrier to resistance makes it particularly effective against multiple HCV genotypes.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 10mg
10-20 days ฿150,000.00
2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
No image available

Used in the treatment of hepatitis C virus (HCV) infection. It acts as a nucleotide analog inhibitor of the NS5B RNA-dependent RNA polymerase, an enzyme essential for viral replication. By incorporating into the growing RNA chain, it causes premature termination of viral RNA synthesis, effectively suppressing the virus. This compound is part of combination antiviral therapies designed to achieve high cure rates with shorter treatment durations and minimal side effects. Its high barrier to resistance make

Used in the treatment of hepatitis C virus (HCV) infection. It acts as a nucleotide analog inhibitor of the NS5B RNA-dependent RNA polymerase, an enzyme essential for viral replication. By incorporating into the growing RNA chain, it causes premature termination of viral RNA synthesis, effectively suppressing the virus. This compound is part of combination antiviral therapies designed to achieve high cure rates with shorter treatment durations and minimal side effects. Its high barrier to resistance makes it particularly effective against multiple HCV genotypes.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Recommended Dosage -
Dosage (Per Day) -
Recommended Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...